NeOnc Reports Early Improvement in Child Receiving NEO100 Under Compassionate Use
NeOnc Technologies reported early clinical improvement in its first child treated with investigational NEO100 under compassionate use in Abu Dhabi. The three-year-old boy with an aggressive brain tumor is breathing without ventilator support, according to treating physicians. Physicians also reported emerging leg movem